CRA International, Inc.
CRA International, Inc. Q1 FY2026 earnings call
May 7, 2026 · fiscal period ended 2026-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-05-07
Management highlights
- CRA continued strong performance in Q1 2026 with revenue growth. Broad-based contributions from eight practices. Growth across geographies. Consultant headcount and utilization improved. - Highlighted markets for services: legal and regulatory services growth in line with broader market, strong M&A activity boosting antitrust practice, finance practice active in complex disputes, forensic services supporting various matters, energy and life sciences practices with double-digit growth. - Took optimization efforts with restructuring charge of $2.6 million, anticipating cost savings and redeploying savings for growth.
Segment performance
Revenue increased by 10.5% year over year to $201 million, the highest quarterly revenue in the company's history. Eight practices grew year over year, with four practices (energy, finance, forensic services, and life sciences) posting double-digit revenue growth, and the antitrust and competition economics practice setting a new quarterly revenue high. North American operations increased revenue by 8.5% and international operations expanded 20.3% year over year. Consultant headcount increased 2.5% compared to Q1 2025, utilization improved to 77%. Legal and regulatory services revenue increased 11.5%. M&A activity was strong with $1.2 trillion in the first quarter of 2026, and CRA's antitrust and competition economics practice had a record quarter. Energy and life sciences practices had double-digit revenue growth. Forensic services supported various matters. The company had a restructuring charge of $2.6 million with anticipated annual cost savings of approximately $5 million.
Guidance
- Reaffirming full year financial guidance for fiscal 2026. Encouraged by strong start, supportive market trends, and robust sales pipeline. Reminding of potential impact from evolving geopolitical, macroeconomic, and business conditions.
Q&A highlights
Q: Asked about demand environment and what's spurring it, Paul responded about complexity driving need for expertise.
Q: Asked about life sciences growth and what's spurring it, Paul said they have multiple quarters of growth with robust lead flow.
Q: Asked about acquisition talent pipeline and forgivable loan amortization in guidance, Paul said guidance doesn't assume inorganic revenue additions but factors in cost burden.
Q: Asked about assignment changes and recruitment, Paul said they're looking for best talent and adding to units.
Q: Asked about utilization improvement and pacing, Paul said utilization was strong from the get-go in 2026.
Q: Asked about complexity on M&A side, Paul said data analysis and market complexity are increasing.
Q: Asked about rate realization and pricing, Paul said they test market for rate increases, with more benefit expected as year progresses.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $1.99 | $2.03 | -1.8% | — |
| Revenue | $201.0M | $194.1M | +3.6% | — |
Transcript
May 7, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.